Sage Therapeutics Inc - Company Profile
Powered by
All the data and insights you need on Sage Therapeutics Inc in one report.
- Save hours of research time and resources with
our up-to-date Sage Therapeutics Inc Strategy Report
- Understand Sage Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
The following section provides information on Sage Therapeutics Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Sage Therapeutics Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Geno Germano
Chairman Executive BoardMr. Geno Germano has been the Chairman of the company since 2024. Previously, he served on the board of directors of the company. He also serves as the President and Chief Executive Officer at Elucida Oncology. He has experience in the pharmaceutical industry and held leadership roles at Intrexon, Pfizer, Wyeth, and Johnson & Johnson.
Barry Greene
Chief Executive Officer; Director Executive BoardMr. Barry Greene has been the Chief Executive Officer and Director of the company since 2020. Prior to this role, he served as President of Alnylam Pharmaceuticals Inc from 2007 to September 2020, and as its Chief Operating Officer from 2003 to 2016.
Kimi Iguchi
Chief Financial Officer Senior ManagementMs. Kimi Iguchi has been the Chief Financial Officer and Treasurer of the company since 2013. Prior to this, she served as the Chief Operating Officer, North America, for Santhera Pharmaceuticals. Ms. Iguchi also served as the Vice President of Finance at Cyberkinetics Neurotechnology Systems, Senior Director of Financial Reporting and Analysis at Millennium Pharmaceuticals and the Senior Manager of External Reporting at Biogen Inc. She also worked as a business assurance manager at PricewaterhouseCoopers LLP and started her career in chemistry-related positions at various Boston-based companies.
Laura Gault, MD, Ph.D
Chief Medical Officer Senior ManagementMr. Laura Gault, MD, Ph.D has been the Chief Medical Officer of the company since November 2022. Prior to this. he served as the Vice President, Therapeutic Area Head for Neurology and Ophthalmology at Alexion/Astra Zeneca Rare Disease. Previously, he served as the Vice President, Neurology Clinic Development at Vertex Pharmaceuticals and Group Project Leader at AbbVie.
Albert Robichaud, Ph.D.
Chief Scientific Officer Senior ManagementDr. Albert J. Robichaud has been the Chief Scientific Officer of the company since 2011. Prior to this, he served as the Vice President of Chemistry and Pharmacokinetic Sciences at Lundbeck Inc. From 2002 to 2010, Dr. Robichaud served as a Senior Director and Head of Neuroscience Discovery Chemistry department of Wyeth Research.
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer